Skip to main content
Q-Linea logo

Q-Linea — Investor Relations & Filings

Ticker · QLINEA ISIN · SE0011527845 LEI · 549300BXVB4XRM8WSC73 ST Manufacturing
Open in API
Filings indexed 322 across all filing types
Latest filing 2025-01-31 Share Issue/Capital Cha…
Country SE Sweden
Listing ST QLINEA

About Q-Linea

https://www.qlinea.com/

Q-Linea is an infection diagnostics company that develops and manufactures solutions for infectious diseases, with a primary focus on sepsis. The company's core product is the ASTar instrument, a fully automated, benchtop system that provides rapid phenotypic antimicrobial susceptibility testing (AST) directly from positive blood cultures. The ASTar system is designed to significantly reduce the time to result compared to traditional diagnostic methods, which can take up to 48 hours. By delivering faster results, the technology enables clinicians to make earlier, more informed decisions on appropriate antibiotic treatments for critically ill patients. This capability aims to improve patient outcomes, support antibiotic stewardship, and help combat the development of antimicrobial resistance.

Recent filings

Filing Released Lang Actions
Q-linea offentliggör preliminärt utfall i företrädesemissionen
Share Issue/Capital Change Classification · 99% confidence The document is a press release titled "Q-linea offentliggör preliminärt utfall i företrädesemissionen" (Q-linea announces preliminary outcome of the rights issue). It details the subscription rate (90.5%) for a rights issue that concluded on January 30, 2025, and mentions the expected date for the final outcome (February 3, 2025). This content directly relates to fundraising and capital structure changes, specifically a rights issue (företrädesemission). This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it is an announcement, the core subject is the financing activity itself, not just the publication of a report, making CAP a more specific fit than RPA or RNS.
2025-01-31 Swedish
Q-linea publishes supplementary prospectus in connection with rights issue
Capital/Financing Update Classification · 98% confidence The document is a press release titled "Q-linea publishes supplementary prospectus in connection with rights issue." It discusses the publication of a Supplementary Prospectus related to an ongoing rights issue, which is a form of capital raising or financing activity. While it mentions a prospectus, the document itself is an announcement about the supplementary document being approved and made available. This strongly aligns with the definition of Capital/Financing Update (CAP). It is not the full 10-K, an earnings release, or a general regulatory filing (RNS), as it pertains specifically to a financing event. Since it details the context and publication of documents related to a rights issue, CAP is the most precise classification.
2025-01-27 English
Q-linea offentliggör tilläggsprospekt avseende företrädesemission
Capital/Financing Update Classification · 98% confidence The document is a press release titled "Q-linea offentliggör tilläggsprospekt avseende företrädesemission" (Q-linea publishes supplementary prospectus regarding rights issue). It explicitly discusses the approval and publication of a supplementary prospectus related to a rights issue (Företrädesemissionen) by the Swedish Financial Supervisory Authority (Finansinspektionen). This activity directly relates to fundraising, financing activities, and capital structure changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP). Although it mentions a prospectus, the document itself is the announcement/press release about the prospectus update, not the full prospectus or the annual report.
2025-01-27 Swedish
Continued commercial progress with US reference laboratory
Regulatory Filings Classification · 95% confidence The document is a short announcement from Q-linea AB regarding continued contract negotiations with a US reference laboratory, anticipating an agreement in February 2025. It provides a brief operational update and includes contact information. The text explicitly states, "Q-linea AB (publ) (OMX: QLINEA) today announces contract negotiations continue..." and concludes with a statement indicating the information is being made public pursuant to the EU Market Abuse Regulation. Given its brevity (2548 characters) and its nature as a timely, non-periodic operational update that doesn't fit the specific definitions for ER, IR, 10-K, or DIRS, it best fits the general category for regulatory announcements that are not otherwise specified, which is Regulatory Filings (RNS). It is not an announcement of a report publication (RPA) because it is reporting on business progress, not the release of a formal financial document.
2025-01-24 English
Fortsatta kommersiella framsteg med amerikanskt referenslaboratorium
Regulatory Filings Classification · 98% confidence The document is a short announcement (2704 characters) in Swedish regarding ongoing commercial progress with a major US reference laboratory, including an expected agreement date (February 2025). It contains contact information, a brief company description, and crucially, a concluding statement: "Denna information är sådan information som Q-linea är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning." (This information is information that Q-linea is obliged to disclose pursuant to the EU Market Abuse Regulation.) This structure strongly suggests a regulatory disclosure intended for immediate public release, often categorized as a general regulatory announcement or press release. Given the short length and the nature of announcing progress rather than releasing full periodic financial data (like 10-K or IR), it does not fit ER, IR, 10-K, or MDA. It is not a dividend notice (DIV), management change (MANG), or director dealing (DIRS). Since it is a mandatory disclosure under MAR but doesn't fit a more specific category like CAP, DVA, or LTR, the most appropriate general category for such regulatory news updates is Regulatory Filings (RNS). If the document were longer and contained detailed financial statements, it might be classified differently, but its brevity and focus on a specific operational update point towards RNS.
2025-01-24 Swedish
Director's Dealing 2025
Director's Dealing Classification · 98% confidence The document details a change in shareholding ('Transaktionen: Sälj') for an entity ('Investment AB Öresund') in Q-linea AB, showing the number of shares and voting rights before and after the transaction. This structure, focusing on insider or major shareholder transactions and reporting changes in ownership percentage (crossing thresholds like 5%), directly corresponds to the definition of Director's Dealing or Major Shareholding Notification. Since the document explicitly details a transaction by a shareholder/investor and reports the resulting holding percentage (0.5%), it fits the 'Major Shareholding Notification' (MRQ) or 'Director's Dealing' (DIRS). Given the context of reporting changes in ownership that cross thresholds (even if the final holding is below 5%, the report is triggered by the transaction), MRQ is highly relevant, but DIRS specifically covers personal share transactions by executives/directors. Since this is an investment company reporting a sale, and the structure is typical of mandatory notifications regarding significant ownership changes, Major Shareholding Notification (MRQ) is the most precise fit for reporting changes in ownership levels crossing thresholds, even if the specific entity isn't a director. However, the structure is also very common for insider trading reports (DIRS). Comparing the definitions: DIRS is for 'personal share transactions by company directors and executives (insider trades)'. MRQ is for 'Notification of changes in significant share ownership levels (crossing thresholds)'. Since the document reports a change in holding that results in 0.5% ownership, and the transaction was a 'Sälj' (Sale), this is a notification of a change in significant share ownership. I will classify it as MRQ as it focuses on the resulting shareholding percentage change.
2025-01-16 Swedish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.